PPDI - Pharmaceutical Product Dev. Inc.COM
This page shows which of the focused investors we track hold PPDI and how their positions changed, so you can see how much conviction the group has in the stock.
In Q2 2011 it was held by 2 managers with an aggregate reported value of $72.47M, which is 0.02% of the combined portfolio.
As of Q2 2011, 2 tracked institutional managers held PPDI (Pharmaceutical Product Dev. Inc.COM) with an aggregate reported value of $72.47M — 0.02% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades PPDI — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q2 2011
- Ticker
- PPDI
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Third Avenue Management - Third Avenue Management | 1.47% | Reduce -2.2% | 2,684,863 | $72.06M |
| 2 | First Eagle - First Eagle Investment Management | 0.00% | - | 15,000 | $403K |
Loading holder history for PPDI…